Cancer Biology Flashcards

1
Q

Basic cancer terminology

A
  • neoplasm (tumour) = a new and abnormal growth
  • benign = grow slowly and remain localised
  • malignant = grows quickly and invades other sites
  • metastasis = when a tumour spreads to another part of the body
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Morphology of neoplastic cells

A
  • become larger with variably shaped nuclei
  • disorganised arrangement due to many dividing cells
  • variation in size and shape
  • loss of normal features
  • become more basophilic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is tumorigenesis?

A

DOUBLE CHECK THIS
Tumorigenesis is the gain of malignant properties in normal cells including:
- dedifferentiation
- fast proliferation
- metastasis
- evasion of apoptosis/immunosurveillance
- dysregulated metabolism and epigenetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the 6 characteristics of cancer cells?

A
  1. Self sufficiency in growth signals: autonomous drive to proliferate
  2. Insensitivity to growth-inhibitory signals: inactivation of tumour suppressor genes that normally inhibit growth
  3. Evasion of apoptosis: suppress and inactivate genes and pathways that normally allow cells to die
  4. Limitless replication potential: activate specific gene pathways that render them immortal even after generations of growth
  5. Sustained angiogenesis: acquire the capacity to draw out their own supply of blood and blood vessels
  6. Tissue invasion and metastasis: acquire the capacity to migrate to other organs, invade other tissues and colonise these organs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Name some growth factors and state their function

A
  1. Colony stimulating factor (CSF) - myeloid lineage in haematopoiesis
  2. Thrombopoietin - production of platelets
  3. Erythropoietin (EPO) - production of RBCs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is an oncogene?

A

A gene whose product is involved in inducing cancer. Most oncogenes are mutated forms of normal genes (proto-oncogenes) involved in the control of cell growth or division

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is a proto-oncogene?

A

A normal cellular gene that encodes a protein usually involved in regulation of cell growth and proliferation, and when mutated, becomes a cancer promoting oncogene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is a tumour suppressor gene?

A

A gene whose encoded protein directly or indirectly inhibits progression through the cell cycle and in which a loss of function mutation is oncogenic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Chronic myeloid leukaemia accounts for 15-20% of adult leukaemias. Which molecular defect is associated with CML?

A

A chromosomal translocation resulting in the bcr-abl fusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How does unregulated cell proliferation occur?

A
  • Molecules that initiate or speed up proliferation are switch on.
  • Molecules that inhibit or slow down proliferation are switched off.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

List some molecules that can be switched on to lead to unregulated cell proliferation.

A
  • hormones - peptide growth factors
  • cell surface receptors (EGFR, HER2, c-Met)
  • cytoplasmic molecules (Ras, BRAF, Abl, Src)
  • nuclear molecules (cyclin D, Myc, Fos, Jun)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How can pronto-oncogenes becomes oncogenes?

A
  • deletion/point mutations
  • regulatory mutations
  • gene amplification
  • chromosome rearrangement
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe a deletion/point mutation in reference to proto-oncogenes becoming oncogenes

A

Hyperactive protein is made in small amounts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe a regulatory mutation in reference to proto-oncogenes becoming oncogenes

A

A normal protein is greatly overproduced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe a gene amplification in reference to proto-oncogenes becoming oncogenes

A

Normal protein greatly overproduced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe a chromosome rearrangement in reference to proto-oncogenes becoming oncogenes

A
  • nearby regulatory DNA sequence causes normal protein to be overproduced
  • fusion to actively transcribed gene produces hyperactive fusion proteins
17
Q

How does RAS contribute to unregulated cell proliferation?

A
  • RAS is GTPase protein that transduces signals from cell surface receptors
  • a point mutation can cause hyperactive RAS that is on all the time
  • this has a dominant effect
  • 30% of all tumours screened carry RAS gene mutations
18
Q

How does BRAF contribute to unregulated cell proliferation?

A
  • BRAF is a kinase that transduces signals from cell surface receptors
  • a point mutation can lead to a hyperactive kinase activity that is on all the time
  • this has a dominant effect
  • 50% of all melanomas have a mutated BRAF
19
Q

How does EGFR contribute to unregulated cell proliferation?

A
  • is a cell surface receptor that receives extra cellular signal
  • deletion of the extracellular portion leads to it being active in the absence of EGF
  • this has a dominant effect
  • eg. Non-small cell lung cancer
20
Q

How does ERB B2 (HER2) contribute to unregulated cell proliferation?

A
  • it is a transmembrane receptor that receives signals from other cells
  • can be affected by gene amplification
  • it is amplified in 20% of breast cancers and indicates a poor prognosis
21
Q

What is the Philadelphia translocation?

A
  • the translocation mutation of BCR gene on chromosome 22 and ABL gene on chromosome 9
  • this leads to the fusion of BCR and ABL to form a BCR-ABL hybrid gene
  • this is found in chronic myeloid leukaemia
22
Q

What happens when tumour suppressor genes are lost or inactivated?
Give examples.

A

Negative regulators of cell proliferation are removed and they contribute to the abnormal proliferation of tumour cells.

  • RB ‘off’ —> retinoblastoma, sarcomas, bladder, breast and lung carcinomas
  • p53 ‘off’ —> brain tumours; breast, colon/rectum, oesophageal, liver and lung carcinomas, sarcomas, leukaemias and lymphomas…this is the most frequently mutated gene in cancer >50%
  • BRCA1 ‘off’ —> breast and ovarian carcinoma
23
Q

What is Li-fraumeni syndrome?

A

An inherited familial predisposition to a wide range of certain cancers
- due to a mutation in p53

24
Q

In order for a cell to metastasise it must breach their basement membrane. Which molecule would help to facilitate this invasive potential?

A

MMP-8 (a protease that degrades collagen as basement membrane contains collagen IV)

25
Q

How can cells evade apoptosis?

A
  • BCL-2 inhibits apoptosis

- increased expression of pro-survival BCL-2 proteins is found in many cancer types e.g. lymphomas

26
Q

How can cells acquire limitless replication potential?

A

Telomeres!

  • in most somatic cells telomeres shorten with age
  • telomerase can ‘add on’ to telomeres aka make them longer
  • increased expression of telomerase immortalises cells in culture
  • telomerase upregulation or reactivation is found in many forms of cancer
27
Q

How can a tumour organise its own blood supply?

A
  • a tumour will initially get nutrients via diffusion
  • it can’t grown beyond 1-2mm in diameter without a blood supply
  • the tumour becomes hypoxic
  • this stimulates the tumour to produce VEGF
  • VEGF induces blood vessels to grow towards tumour
28
Q

How can a tumour metastasise?

A
  • defective adherens junction: epithelial tumours often lose E-cadherin (part of junction) partially or completely
  • defective ECM junctions: integrins form part of cell-ECM junctions, altered integrin expression is often detected in tumours
  • tumours can ‘chew’ through via matrix metalloproteinases (MMPs) e.g. MMP-8 or urokinase plasminogen activator (uPA)
29
Q

Name 4 drugs that target oncogenic pathways

A
  1. Trastuzmab (Herceptin) targets HER2 in breast cancer
  2. Bevacizumab targets VEGF in colorectal and non-small cell lung cancer
  3. Imatinib targets ABL in chronic myeloid leukaemia
  4. Vemurafenib targets BRAF in melanoma